TreeWAS – Variant ID: rs4719147

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.052	0.948	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.050	0.950	0.000
T43.2 Other and unspecified antidepressants	0.047	0.953	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.047	0.953	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.046	0.954	0.000
T43.6 Psychostimulants with abuse potential	0.045	0.955	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.044	0.955	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.043	0.957	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.041	0.958	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.040	0.960	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.040	0.960	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.040	0.960	0.000
T43.9 Psychotropic drug, unspecified	0.038	0.962	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.038	0.962	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.038	0.962	0.000
T36 Poisoning by systemic antibiotics	0.038	0.962	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.037	0.963	0.000
T50.4 Drugs affecting uric acid metabolism	0.036	0.963	0.000
T39.0 Salicylates	0.036	0.964	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.035	0.964	0.000
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.964	0.036
T47.0 Histamine H(2)-receptor antagonists	0.034	0.966	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.034	0.966	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.034	0.966	0.000
T47.6 Antidiarrhoeal drugs	0.034	0.966	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.033	0.967	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.033	0.967	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.033	0.967	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.032	0.968	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.032	0.968	0.000
T50.7 Analeptics and opioid receptor antagonists	0.032	0.968	0.000
T50.5 Appetite depressants	0.032	0.968	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.032	0.968	0.000
T50.1 Loop [high-ceiling] diuretics	0.032	0.968	0.000
T50.0 Mineralocorticoids and their antagonists	0.032	0.968	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.032	0.968	0.000
T45.2 Vitamins, not elsewhere classified	0.032	0.968	0.000
T45.5 Anticoagulants	0.032	0.968	0.000
T50.8 Diagnostic agents	0.032	0.968	0.000
T47.2 Stimulant laxatives	0.031	0.968	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.031	0.969	0.000
T45.4 Iron and its compounds	0.031	0.969	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.031	0.969	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.030	0.970	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.030	0.970	0.000
T47.7 Emetics	0.030	0.970	0.000
T47.5 Digestants	0.030	0.970	0.000
T47.3 Saline and osmotic laxatives	0.030	0.970	0.000
T36.3 Macrolides	0.030	0.970	0.000
T36.4 Tetracyclines	0.029	0.971	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.029	0.971	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.029	0.971	0.000
T39.1 4-Aminophenol derivatives	0.029	0.971	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.029	0.971	0.000
T42.4 Benzodiazepines	0.029	0.971	0.000
T39.4 Antirheumatics, not elsewhere classified	0.029	0.971	0.000
T39.2 Pyrazolone derivatives	0.029	0.971	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.029	0.971	0.000
T45.8 Other primarily systemic and haematological agents	0.029	0.971	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.029	0.971	0.000
T45.6 Fibrinolysis-affecting drugs	0.029	0.971	0.000
T45.3 Enzymes, not elsewhere classified	0.029	0.971	0.000
T42.0 Hydantoin derivatives	0.028	0.972	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.028	0.972	0.000
T36.0 Penicillins	0.028	0.972	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.027	0.972	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.027	0.972	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.027	0.972	0.000
T42.2 Succinimides and oxazolidinediones	0.027	0.972	0.000
T42.3 Barbiturates	0.027	0.973	0.000
T36.9 Systemic antibiotic, unspecified	0.027	0.973	0.000
T36.7 Antifungal antibiotics, systemically used	0.027	0.973	0.000
T36.6 Rifamycins	0.027	0.973	0.000
T36.5 Aminoglycosides	0.027	0.973	0.000
T36.2 Chloramphenicol group	0.027	0.973	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.027	0.973	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.027	0.973	0.000
T37.5 Antiviral drugs	0.027	0.973	0.000
T37.4 Anthelminthics	0.027	0.973	0.000
T37.3 Other antiprotozoal drugs	0.027	0.973	0.000
T37.1 Antimycobacterial drugs	0.027	0.973	0.000
T37.0 Sulphonamides	0.027	0.973	0.000
T45.0 Antiallergic and antiemetic drugs	0.027	0.973	0.000
T36.8 Other systemic antibiotics	0.026	0.974	0.000
T47.4 Other laxatives	0.025	0.974	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.025	0.975	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.025	0.975	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.024	0.975	0.000
T41.5 Therapeutic gases	0.024	0.975	0.000
T41.4 Anaesthetic, unspecified	0.024	0.975	0.000
T41.3 Local anaesthetics	0.024	0.975	0.000
T41.2 Other and unspecified general anaesthetics	0.024	0.975	0.000
T41.1 Intravenous anaesthetics	0.024	0.975	0.000
T41.0 Inhaled anaesthetics	0.024	0.975	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.024	0.975	0.000
T48.4 Expectorants	0.024	0.975	0.000
T48.3 Antitussives	0.024	0.975	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.024	0.975	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.024	0.975	0.000
T48.0 Oxytocic drugs	0.024	0.975	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.024	0.975	0.000
T48.5 Anti-common-cold drugs	0.024	0.976	0.000
T49.9 Topical agent, unspecified	0.024	0.976	0.000
T49.8 Other topical agents	0.024	0.976	0.000
T49.7 Dental drugs, topically applied	0.024	0.976	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.024	0.976	0.000
T49.5 Ophthalmological drugs and preparations	0.024	0.976	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.024	0.976	0.000
T49.3 Emollients, demulcents and protectants	0.024	0.976	0.000
T49.2 Local astringents and local detergents	0.024	0.976	0.000
T49.1 Antipruritics	0.024	0.976	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.024	0.976	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.023	0.976	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.023	0.977	0.000
T46.7 Peripheral vasodilators	0.023	0.977	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.023	0.977	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.023	0.977	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.022	0.978	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.022	0.978	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.022	0.978	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.022	0.978	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.020	0.980	0.000
N19 Unspecified renal failure	0.000	0.980	0.020
T46.1 Calcium-channel blockers	0.019	0.981	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.019	0.981	0.000
T38.0 Glucocorticoids and synthetic analogues	0.018	0.982	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.018	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.018	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.018	0.982	0.000
T44.0 Anticholinesterase agents	0.018	0.982	0.000
T38.9 Other and unspecified hormone antagonists	0.018	0.982	0.000
T38.7 Androgens and anabolic congeners	0.018	0.982	0.000
T38.5 Other oestrogens and progestogens	0.018	0.982	0.000
T38.4 Oral contraceptives	0.018	0.982	0.000
T38.2 Antithyroid drugs	0.018	0.982	0.000
T42.1 Iminostilbenes	0.018	0.982	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.017	0.982	0.000
T38.1 Thyroid hormones and substitutes	0.017	0.983	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.016	0.984	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.016	0.984	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.016	0.984	0.000
T40.1 Heroin	0.016	0.984	0.000
Z91.5 Personal history of self-harm	0.016	0.984	0.000
K75.4 Autoimmune hepatitis	0.000	0.984	0.016
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.016	0.984	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.015	0.984	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.985	0.015
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.985	0.000
T40.8 Lysergide [LSD]	0.015	0.985	0.000
T40.7 Cannabis (derivatives)	0.015	0.985	0.000
T40.0 Opium	0.015	0.985	0.000
T40.3 Methadone	0.015	0.985	0.000
T40.5 Cocaine	0.014	0.985	0.000
K75 Other inflammatory liver diseases	0.000	0.986	0.014
T40.4 Other synthetic narcotics	0.014	0.986	0.000
T40.6 Other and unspecified narcotics	0.012	0.987	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.989	0.011
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.989	0.000
K75.8 Other specified inflammatory liver diseases	0.000	0.990	0.010
K75.2 Nonspecific reactive hepatitis	0.000	0.990	0.010
K75.1 Phlebitis of portal vein	0.000	0.990	0.010
K75.0 Abscess of liver	0.000	0.990	0.010
N13 Obstructive and reflux uropathy	0.000	0.990	0.010
N13.3 Other and unspecified hydronephrosis	0.000	0.990	0.010
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.000	0.990	0.010
Z95.0 Presence of cardiac pacemaker	0.009	0.991	0.000
O36.8 Maternal care for other specified foetal problems	0.000	0.991	0.009
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.991	0.009
J30.1 Allergic rhinitis due to pollen	0.000	0.991	0.009
F60.3 Emotionally unstable personality disorder	0.009	0.991	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.992	0.008
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.992	0.008
R47.8 Other and unspecified speech disturbances	0.000	0.992	0.008
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.992	0.008
N13.8 Other obstructive and reflux uropathy	0.000	0.992	0.008
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.992	0.008
O36 Maternal care for other known or suspected foetal problems	0.000	0.992	0.008
F60 Specific personality disorders	0.008	0.992	0.000
R47 Speech disturbances, not elsewhere classified	0.000	0.992	0.008
O36.0 Maternal care for rhesus isoimmunisation	0.000	0.992	0.008
H25.9 Senile cataract, unspecified	0.000	0.993	0.007
R49.0 Dysphonia	0.000	0.993	0.007
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.007	0.993	0.000
R47.0 Dysphasia and aphasia	0.000	0.993	0.007
O36.3 Maternal care for signs of foetal hypoxia	0.000	0.993	0.007
T40.2 Other opioids	0.007	0.993	0.000
O36.4 Maternal care for intra-uterine death	0.000	0.993	0.007
N10-N16 Renal tubulo-interstitial diseases	0.000	0.993	0.007
R49 Voice disturbances	0.000	0.993	0.007
I63 Cerebral infarction	0.000	0.993	0.007
J30 Vasomotor and allergic rhinitis	0.000	0.993	0.007
F60.7 Dependent personality disorder	0.006	0.993	0.000
F60.6 Anxious [avoidant] personality disorder	0.006	0.994	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.994	0.006
R47.1 Dysarthria and anarthria	0.000	0.994	0.006
R59.1 Generalised enlarged lymph nodes	0.006	0.994	0.000
F60.9 Personality disorder, unspecified	0.006	0.994	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.000	0.994	0.006
F60.2 Dissocial personality disorder	0.006	0.994	0.000
N15 Other renal tubulo-interstitial diseases	0.000	0.994	0.006
O36.9 Maternal care for foetal problem, unspecified	0.000	0.994	0.006
J30.3 Other allergic rhinitis	0.000	0.994	0.006
F60.5 Anankastic personality disorder	0.006	0.994	0.000
O36.1 Maternal care for other isoimmunisation	0.000	0.994	0.006
O36.6 Maternal care for excessive foetal growth	0.000	0.994	0.006
S82.8 Fractures of other parts of lower leg	0.006	0.994	0.000
R47-R49 Symptoms and signs involving speech and voice	0.000	0.994	0.006
N15.9 Renal tubulo-interstitial disease, unspecified	0.000	0.994	0.006
R49.8 Other and unspecified voice disturbances	0.000	0.994	0.006
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.000	0.994	0.006
F60.4 Histrionic personality disorder	0.006	0.994	0.000
F60.1 Schizoid personality disorder	0.006	0.994	0.000
O36.2 Maternal care for hydrops foetalis	0.000	0.994	0.006
M47.80 Other spondylosis (Multiple sites in spine)	0.000	0.994	0.006
M79.60 Pain in limb (Multiple sites)	0.006	0.994	0.000
K43 Ventral hernia	0.000	0.994	0.005
F60.8 Other specific personality disorders	0.006	0.994	0.000
N13.6 Pyonephrosis	0.000	0.994	0.005
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.994	0.006
J30.4 Allergic rhinitis, unspecified	0.000	0.995	0.005
F60-F69 Disorders of adult personality and behaviour	0.005	0.995	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.995	0.005
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.000	0.995	0.005
J30.0 Vasomotor rhinitis	0.000	0.995	0.005
F60.0 Paranoid personality disorder	0.005	0.995	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.000	0.995	0.005
R49.2 Hypernasality and hyponasality	0.000	0.995	0.005
I63.8 Other cerebral infarction	0.000	0.995	0.005
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.000	0.995	0.005
F69 Unspecified disorder of adult personality and behaviour	0.005	0.995	0.000
N15.1 Renal and perinephric abscess	0.000	0.995	0.005
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.000	0.995	0.005
N15.8 Other specified renal tubulo-interstitial diseases	0.000	0.995	0.005
N15.0 Balkan nephropathy	0.000	0.995	0.005
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.000	0.995	0.005
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.000	0.995	0.005
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.000	0.995	0.005
N13.4 Hydroureter	0.000	0.995	0.004
U89.8 Agent resistant to other single specified antibiotic	0.000	0.995	0.005
F61 Mixed and other personality disorders	0.004	0.995	0.000
S82.86 Maisonneuve's fracture	0.004	0.995	0.000
N11 Chronic tubulo-interstitial nephritis	0.000	0.996	0.004
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.996	0.004
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.996	0.004
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.996	0.004
K43.4 Parastomal hernia with gangrene	0.000	0.996	0.004
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.996	0.004
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.996	0.004
R49.1 Aphonia	0.000	0.996	0.004
N10 Acute tubulo-interstitial nephritis	0.000	0.996	0.004
F64 Gender identity disorders	0.004	0.996	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.004	0.996	0.000
F65 Disorders of sexual preference	0.004	0.996	0.000
F63 Habit and impulse disorders	0.004	0.996	0.000
F68 Other disorders of adult personality and behaviour	0.004	0.996	0.000
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.000	0.996	0.004
F62 Enduring personality changes, not attributable to brain damage and disease	0.004	0.996	0.000
K43.1 Ventral hernia with gangrene	0.001	0.996	0.003
S82.81 Fractures of other parts of lower leg (open)	0.004	0.996	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.004	0.996	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.000	0.996	0.003
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.000	0.996	0.003
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.000	0.996	0.003
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.000	0.996	0.003
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.000	0.996	0.003
K86.2 Cyst of pancreas	0.000	0.996	0.004
N14.4 Toxic nephropathy, not elsewhere classified	0.000	0.996	0.003
N14.3 Nephropathy induced by heavy metals	0.000	0.996	0.003
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.000	0.996	0.003
N14.0 Analgesic nephropathy	0.000	0.996	0.003
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.000	0.996	0.003
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.000	0.996	0.003
R27.8 Other and unspecified lack of coordination	0.004	0.996	0.000
B44.9 Aspergillosis, unspecified	0.000	0.996	0.004
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.003
F64.0 Transsexualism	0.003	0.996	0.000
U89 Agent resistant to other and unspecified antibiotics	0.000	0.997	0.003
N11.8 Other chronic tubulo-interstitial nephritis	0.000	0.997	0.003
N11.1 Chronic obstructive pyelonephritis	0.000	0.997	0.003
F64.9 Gender identity disorder, unspecified	0.003	0.997	0.000
F64.8 Other gender identity disorders	0.003	0.997	0.000
F64.2 Gender identity disorder of childhood	0.003	0.997	0.000
F64.1 Dual-role transvestism	0.003	0.997	0.000
S60.8 Other superficial injuries of wrist and hand	0.000	0.997	0.003
M47.86 Other spondylosis (Lumbar region)	0.003	0.997	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.000	0.997	0.003
F63.9 Habit and impulse disorder, unspecified	0.003	0.997	0.000
F63.8 Other habit and impulse disorders	0.003	0.997	0.000
F63.3 Trichotillomania	0.003	0.997	0.000
F63.2 Pathological stealing [kleptomania]	0.003	0.997	0.000
F63.1 Pathological fire-setting [pyromania]	0.003	0.997	0.000
F63.0 Pathological gambling	0.003	0.997	0.000
F65.9 Disorder of sexual preference, unspecified	0.003	0.997	0.000
F65.8 Other disorders of sexual preference	0.003	0.997	0.000
F65.6 Multiple disorders of sexual preference	0.003	0.997	0.000
F65.5 Sadomasochism	0.003	0.997	0.000
F65.4 Paedophilia	0.003	0.997	0.000
F65.3 Voyeurism	0.003	0.997	0.000
F65.2 Exhibitionism	0.003	0.997	0.000
F65.1 Fetishistic transvestism	0.003	0.997	0.000
F65.0 Fetishism	0.003	0.997	0.000
F66.9 Psychosexual development disorder, unspecified	0.003	0.997	0.000
F66.8 Other psychosexual development disorders	0.003	0.997	0.000
F66.2 Sexual relationship disorder	0.003	0.997	0.000
F66.1 Egodystonic sexual orientation	0.003	0.997	0.000
F66.0 Sexual maturation disorder	0.003	0.997	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.003	0.997	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.003	0.997	0.000
R48.2 Apraxia	0.000	0.997	0.003
R48.1 Agnosia	0.000	0.997	0.003
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.003	0.997	0.000
B44.1 Other pulmonary aspergillosis	0.000	0.997	0.003
B44 Aspergillosis	0.000	0.997	0.003
F62.8 Other enduring personality changes	0.003	0.997	0.000
F62.1 Enduring personality change after psychiatric illness	0.003	0.997	0.000
F62.0 Enduring personality change after catastrophic experience	0.003	0.997	0.000
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
D07.5 Prostate	0.003	0.997	0.000
D07.1 Vulva	0.003	0.997	0.000
R48.8 Other and unspecified symbolic dysfunctions	0.000	0.997	0.003
I63.9 Cerebral infarction, unspecified	0.000	0.997	0.003
B35.1 Tinea unguium	0.000	0.997	0.003
R48.0 Dyslexia and alexia	0.000	0.997	0.003
U88 Agent resistant to multiple antibiotics	0.000	0.997	0.003
Z83.7 Family history of diseases of the digestive system	0.000	0.997	0.003
O40 Polyhydramnios	0.000	0.997	0.003
C15.4 Middle third of oesophagus	0.003	0.997	0.000
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
F62.9 Enduring personality change, unspecified	0.002	0.997	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.997	0.003
U89.9 Agent resistant to unspecified antibiotic	0.000	0.997	0.003
B35 Dermatophytosis	0.000	0.997	0.003
D07 Carcinoma in situ of other and unspecified genital organs	0.003	0.997	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.997	0.003
O36.5 Maternal care for poor foetal growth	0.000	0.997	0.003
B35.6 Tinea cruris	0.000	0.997	0.003
I42.8 Other cardiomyopathies	0.000	0.997	0.003
W19.3 Sports and athletics area	0.000	0.997	0.003
C22.0 Liver cell carcinoma	0.003	0.997	0.000
B44.8 Other forms of aspergillosis	0.000	0.997	0.002
B44.7 Disseminated aspergillosis	0.000	0.997	0.002
B44.2 Tonsillar aspergillosis	0.000	0.997	0.002
B44.0 Invasive pulmonary aspergillosis	0.000	0.997	0.002
D07.2 Vagina	0.002	0.997	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
S83.2 Tear of meniscus, current	0.002	0.998	0.000
W50.9 Unspecified place	0.000	0.998	0.002
I77.8 Other specified disorders of arteries and arterioles	0.002	0.998	0.000
Z88.5 Personal history of allergy to narcotic agent	0.000	0.998	0.002
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.002	0.998	0.000
D07.4 Penis	0.002	0.998	0.000
O16 Unspecified maternal hypertension	0.000	0.998	0.002
C15.9 Oesophagus, unspecified	0.002	0.998	0.000
B35.3 Tinea pedis	0.000	0.998	0.002
F33.0 Recurrent depressive disorder, current episode mild	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.000	0.998	0.002
B35.5 Tinea imbricata	0.000	0.998	0.002
B35.2 Tinea manuum	0.000	0.998	0.002
B35.0 Tinea barbae and tinea capitis	0.000	0.998	0.002
D07.6 Other and unspecified male genital organs	0.002	0.998	0.000
D07.3 Other and unspecified female genital organs	0.002	0.998	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.998	0.002
U83 Resistance to other antibiotics	0.000	0.998	0.002
U82 Resistance to betalactam antibiotics	0.000	0.998	0.002
U85 Resistance to antineoplastic drugs	0.000	0.998	0.002
B35.9 Dermatophytosis, unspecified	0.000	0.998	0.002
K74.6 Other and unspecified cirrhosis of liver	0.002	0.998	0.000
C15 Malignant neoplasm of oesophagus	0.002	0.998	0.000
F33 Recurrent depressive disorder	0.002	0.998	0.000
B35.4 Tinea corporis	0.000	0.998	0.002
D07.0 Endometrium	0.002	0.998	0.000
I49.5 Sick sinus syndrome	0.002	0.998	0.000
K43.0 Ventral hernia with obstruction, without gangrene	0.001	0.998	0.001
C15.3 Upper third of oesophagus	0.002	0.998	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
B35-B49 Mycoses	0.000	0.998	0.002
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.998	0.002
I47.2 Ventricular tachycardia	0.002	0.998	0.000
G80 Infantile cerebral palsy	0.002	0.998	0.000
C15.0 Cervical part of oesophagus	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.002	0.998	0.000
M23.8 Other internal derangements of knee	0.002	0.998	0.000
B49 Unspecified mycosis	0.000	0.998	0.002
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
Z83.3 Family history of diabetes mellitus	0.000	0.998	0.002
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.002	0.998	0.000
K09.0 Developmental odontogenic cysts	0.002	0.998	0.000
S91.3 Open wound of other parts of foot	0.002	0.998	0.000
N75.1 Abscess of Bartholin's gland	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.000	0.998	0.002
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.998	0.002
U82.8 Resistance to other betalactam antibiotics	0.000	0.998	0.002
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.998	0.002
U82.1 Resistance to methicillin	0.000	0.998	0.002
U82.0 Resistance to penicillin	0.000	0.998	0.002
U83.9 Resistance to unspecified antibiotic	0.000	0.998	0.002
U83.8 Resistance to other single specified antibiotic	0.000	0.998	0.002
U83.7 Resistance to multiple antibiotics	0.000	0.998	0.002
U83.2 Resistance to quinolones	0.000	0.998	0.002
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.998	0.002
U83.0 Resistance to vancomycin	0.000	0.998	0.002
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.998	0.002
U84.8 Resistance to other specified antimicrobial drug	0.000	0.998	0.002
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.998	0.002
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.998	0.002
U84.2 Resistance to antiviral drug(s)	0.000	0.998	0.002
U84.1 Resistance to antifungal drug(s)	0.000	0.998	0.002
U84.0 Resistance to antiparasitic drug(s)	0.000	0.998	0.002
I45.5 Other specified heart block	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.002	0.998	0.000
C15.2 Abdominal part of oesophagus	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.002	0.998	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
K10.8 Other specified diseases of jaws	0.000	0.998	0.002
G80.8 Other infantile cerebral palsy	0.002	0.998	0.000
B47 Mycetoma	0.000	0.998	0.002
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.002	0.998	0.000
B48 Other mycoses, not elsewhere classified	0.000	0.998	0.002
B46 Zygomycosis	0.000	0.998	0.002
B45 Cryptococcosis	0.000	0.998	0.002
B43 Chromomycosis and phaeomycotic abscess	0.000	0.998	0.002
B42 Sporotrichosis	0.000	0.998	0.002
B41 Paracoccidioidomycosis	0.000	0.998	0.002
B40 Blastomycosis	0.000	0.998	0.002
B39 Histoplasmosis	0.000	0.998	0.002
B38 Coccidioidomycosis	0.000	0.998	0.002
B36 Other superficial mycoses	0.000	0.998	0.002
N90.7 Vulvar cyst	0.000	0.998	0.002
N17-N19 Renal failure	0.000	0.998	0.002
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
F33.8 Other recurrent depressive disorders	0.002	0.998	0.000
K11.1 Hypertrophy of salivary gland	0.002	0.998	0.000
K10.0 Developmental disorders of jaws	0.000	0.998	0.002
X59.3 Sports and athletics area	0.002	0.998	0.000
C15.1 Thoracic part of oesophagus	0.002	0.998	0.000
G80.4 Ataxic cerebral palsy	0.002	0.998	0.000
G80.3 Dyskinetic cerebral palsy	0.002	0.998	0.000
O45.9 Premature separation of placenta, unspecified	0.000	0.998	0.002
M23.87 Other internal derangements of knee (Capsular ligament)	0.002	0.998	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.002	0.998	0.000
C54.1 Endometrium	0.000	0.998	0.002
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.998	0.002
C15.5 Lower third of oesophagus	0.002	0.998	0.000
Z83 Family history of other specific disorders	0.000	0.998	0.002
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.001	0.998	0.000
W57.0 Home	0.000	0.998	0.002
M23.80 Other internal derangements of knee (Multiple sites)	0.002	0.998	0.000
B47.9 Mycetoma, unspecified	0.000	0.998	0.001
D75.9 Disease of blood and blood-forming organs, unspecified	0.002	0.998	0.000
G80.1 Spastic diplegia	0.001	0.998	0.000
Z83.6 Family history of diseases of the respiratory system	0.000	0.998	0.002
B47.1 Actinomycetoma	0.000	0.998	0.001
B47.0 Eumycetoma	0.000	0.998	0.001
C22.7 Other specified carcinomas of liver	0.001	0.998	0.000
C22.4 Other sarcomas of liver	0.001	0.998	0.000
C22.3 Angiosarcoma of liver	0.001	0.998	0.000
C22.2 Hepatoblastoma	0.001	0.998	0.000
G80.0 Spastic cerebral palsy	0.001	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.000	0.998	0.001
B38.8 Other forms of coccidioidomycosis	0.000	0.998	0.001
B38.7 Disseminated coccidioidomycosis	0.000	0.998	0.001
B38.4 Coccidioidomycosis meningitis	0.000	0.998	0.001
B38.3 Cutaneous coccidioidomycosis	0.000	0.998	0.001
B38.2 Pulmonary coccidioidomycosis, unspecified	0.000	0.998	0.001
B38.1 Chronic pulmonary coccidioidomycosis	0.000	0.998	0.001
B38.0 Acute pulmonary coccidioidomycosis	0.000	0.998	0.001
B39.9 Histoplasmosis, unspecified	0.000	0.998	0.001
B39.5 Histoplasmosis duboisii	0.000	0.998	0.001
B39.4 Histoplasmosis capsulati, unspecified	0.000	0.998	0.001
B39.3 Disseminated histoplasmosis capsulati	0.000	0.998	0.001
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.000	0.998	0.001
B39.1 Chronic pulmonary histoplasmosis capsulati	0.000	0.998	0.001
B39.0 Acute pulmonary histoplasmosis capsulati	0.000	0.998	0.001
B40.9 Blastomycosis, unspecified	0.000	0.998	0.001
B40.8 Other forms of blastomycosis	0.000	0.998	0.001
B40.7 Disseminated blastomycosis	0.000	0.998	0.001
B40.3 Cutaneous blastomycosis	0.000	0.998	0.001
B40.2 Pulmonary blastomycosis, unspecified	0.000	0.998	0.001
B40.1 Chronic pulmonary blastomycosis	0.000	0.998	0.001
B40.0 Acute pulmonary blastomycosis	0.000	0.998	0.001
B41.9 Paracoccidioidomycosis, unspecified	0.000	0.998	0.001
B41.8 Other forms of paracoccidioidomycosis	0.000	0.998	0.001
B41.7 Disseminated paracoccidioidomycosis	0.000	0.998	0.001
B41.0 Pulmonary paracoccidioidomycosis	0.000	0.998	0.001
B42.9 Sporotrichosis, unspecified	0.000	0.998	0.001
B42.8 Other forms of sporotrichosis	0.000	0.998	0.001
B42.7 Disseminated sporotrichosis	0.000	0.998	0.001
B42.1 Lymphocutaneous sporotrichosis	0.000	0.998	0.001
B42.0 Pulmonary sporotrichosis	0.000	0.998	0.001
B43.9 Chromomycosis, unspecified	0.000	0.998	0.001
B43.8 Other forms of chromomycosis	0.000	0.998	0.001
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations